Decoding caspase signaling in host immunity to the protozoan Trypanosoma cruzi

Trends in Immunology

Volumn 28, Issue 8, 2007, Pages 366-372

  Lopes, Marcela F ^a   Guillermo, Landi V C ^a   Silva, Elisabeth M ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BENZNIDAZOLE; BETA GALACTOSIDASE; CASPASE; CASPASE INHIBITOR; CYTOKINE; FAS LIGAND; INTERLEUKIN 4 ANTIBODY; KETONE DERIVATIVE; MONOCLONAL ANTIBODY; VIRUS PROTEIN;

APOPTOSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL TRIAL; CYTOKINE RELEASE; ENZYME ACTIVATION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; MACROPHAGE; NONHUMAN; PROTOZOAL INFECTION; PROTOZOON; REVIEW; SEPSIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TRYPANOSOMA CRUZI;

ANIMALS; APOPTOSIS; CASPASES; CHAGAS DISEASE; CYTOKINES; HUMANS; IMMUNITY, NATURAL; LYMPHOCYTE ACTIVATION; MACROPHAGES; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 34447523344     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2007.06.004     Document Type: Review

References (68)

1. McMahon-Pratt D., and Alexander J. Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease?. Immunol. Rev. 201 (2004) 206-224
2. Hunter C.A., et al. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J. Immunol. 158 (1997) 3311-3316
3. Gomes J.A., et al. Type 1 chemokine receptor expression in Chagas' disease correlates with morbidity in cardiac patients. Infect. Immun. 73 (2005) 7960-7966
4. Wipasa J., et al. Apoptotic deletion of Th cells specific for the 19-kDa carboxyl-terminal fragment of merozoite surface protein 1 during malaria infection. J. Immunol. 167 (2001) 3903-3909
5. + T cell death by apoptosis in experimental Chagas' disease. J. Immunol. 154 (1995) 744-752
6. de Meis J., et al. Atrophy of mesenteric lymph nodes in experimental Chagas' disease: differential role of Fas/Fas-L and TNFRI/TNF pathways. Microbes Infect. 8 (2006) 221-231
7. Tostes Jr. S., et al. Myocardiocyte apoptosis in heart failure in chronic Chagas' disease. Int. J. Cardiol. 99 (2005) 233-237
8. Zuniga E., et al. Trypanosoma cruzi-induced immunosuppression: B cells undergo spontaneous apoptosis and lipopolysaccharide (LPS) arrests their proliferation during acute infection. Clin. Exp. Immunol. 119 (2000) 507-515
9. Luder C.G., et al. Intracellular protozoan parasites and apoptosis: diverse strategies to modulate parasite-host interactions. Trends Parasitol. 17 (2001) 480-486
10. James E.R., and Green D.R. Manipulation of apoptosis in the host-parasite interaction. Trends Parasitol. 20 (2004) 280-287
11. Carrero J.A., and Unanue E.R. Lymphocyte apoptosis as an immune subversion strategy of microbial pathogens. Trends Immunol. 27 (2006) 497-503
12. DosReis G.A., et al. The importance of aberrant T-cell responses in Chagas disease. Trends Parasitol. 21 (2005) 237-243
13. Martins G.A., et al. Nitric oxide-induced apoptotic cell death in the acute phase of Trypanosoma cruzi infection in mice. Immunol. Lett. 63 (1998) 113-120
14. Martins G.A., et al. Fas-FasL interaction modulates nitric oxide production in Trypanosoma cruzi-infected mice. Immunology 103 (2001) 122-129
15. Lopes M.F., and DosReis G.A. Trypanosoma cruzi-induced immunosuppression: selective triggering of CD4+ T-cell death by the T-cell receptor-CD3 pathway and not by the CD69 or Ly-6 activation pathway. Infect. Immun. 64 (1996) 1559-1564
16. Lopes M.F., et al. The macrophage haunted by cell ghosts: a pathogen grows. Immunol. Today 21 (2000) 489-494
17. Voll R.E., et al. Immunosuppressive effects of apoptotic cells. Nature 390 (1997) 350-351
18. Fadok V.A., et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF. J. Clin. Invest. 101 (1998) 890-898
19. + T lymphocytes from infected hosts. J. Immunol. 160 (1998) 1313-1319
20. Freire-de-Lima C.G., et al. Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages. Nature 403 (2000) 199-203
21. Paiva C.N., et al. Unraveling the lethal synergism between Trypanosoma cruzi infection and LPS: a role for increased macrophage reactivity. Eur. J. Immunol. 37 (2007) 1355-1364
22. Melo R.C., and Machado C.R. Trypanosoma cruzi: peripheral blood monocytes and heart macrophages in the resistance to acute experimental infection in rats. Exp. Parasitol. 97 (2001) 15-23
23. Ribeiro-Gomes F.L., et al. Macrophage interactions with neutrophils regulate Leishmania major infection. J. Immunol. 172 (2004) 4454-4462
24. Zhang X.R., et al. Reciprocal expression of TRAIL and CD95L in Th1 and Th2 cells: role of apoptosis in T helper subset differentiation. Cell Death Differ. 10 (2003) 203-210
25. + T-cell memory via TRAIL-mediated activation-induced cell death. Nature 434 (2005) 88-93
26. Zheng L., et al. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377 (1995) 348-351
27. Hildeman D.A., et al. Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim. Immunity 16 (2002) 759-767
28. Alves N.L., et al. Withdrawal symptoms on display: Bcl-2 members under investigation. Trends Immunol. 28 (2007) 26-32
29. Lopes M.F., et al. Increased susceptibility of Fas ligand-deficient gld mice to Trypanosoma cruzi infection due to a Th2-biased host immune response. Eur. J. Immunol. 29 (1999) 81-89
30. Guillermo L.V., et al. The Fas death pathway controls coordinated expansions of type 1 CD8 and type 2 CD4 T cells in Trypanosoma cruzi infection. J. Leukoc. Biol. 81 (2007) 942-951
31. Shi Y. Caspase activation: revisiting the induced proximity model. Cell 117 (2004) 855-858
32. Silva E.M., et al. Caspase-8 activity prevents type 2 cytokine responses and is required for protective T cell-mediated immunity against Trypanosoma cruzi infection. J. Immunol. 174 (2005) 6314-6321
33. Silva E.M., et al. Caspase inhibition reduces lymphocyte apoptosis and improves host immune responses to Trypanosoma cruzi infection. Eur. J. Immunol. 37 (2007) 738-746
34. Martins G.A., et al. Gamma interferon modulates CD95 (Fas) and CD95 ligand (Fas-L) expression and nitric oxide-induced apoptosis during the acute phase of Trypanosoma cruzi infection: a possible role in immune response control. Infect. Immun. 67 (1999) 3864-3871
35. Silva J.S., et al. Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages. Infect. Immun. 63 (1995) 4862-4867
36. Todeschini A.R., et al. Costimulation of host T lymphocytes by a trypanosomal trans-sialidase: involvement of CD43 signaling. J. Immunol. 168 (2002) 5192-5198
37. Leguizamon M.S., et al. Trans-sialidase from Trypanosoma cruzi induces apoptosis in cells from the immune system in vivo. J. Infect. Dis. 180 (1999) 1398-1402
38. Mucci J., et al. Thymocyte depletion in Trypanosoma cruzi infection is mediated by trans-sialidase-induced apoptosis on nurse cells complex. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 3896-3901
39. Green D.R., and Kroemer G. Pharmacological manipulation of cell death: clinical applications in sight?. J. Clin. Invest. 115 (2005) 2610-2617
40. Lavrik I.N., et al. Caspases: pharmacological manipulation of cell death. J. Clin. Invest. 115 (2005) 2665-2672
41. Hotchkiss R.S., et al. Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 14541-14546
42. Hotchkiss R.S., et al. Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat. Immunol. 1 (2000) 496-501
43. Lasbury M.E., et al. Suppression of alveolar macrophage apoptosis prolongs survival of rats and mice with pneumocystis pneumonia. J. Immunol. 176 (2006) 6443-6453
44. Hotchkiss R.S., et al. Adoptive transfer of apoptotic splenocytes worsens survival, whereas adoptive transfer of necrotic splenocytes improves survival in sepsis. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 6724-6729
45. + T cell memory. J. Immunol. 172 (2004) 6313-6323
46. Su H., et al. Requirement for caspase-8 in NF-κB activation by antigen receptor. Science 307 (2005) 1465-1468
47. Chun H.J., et al. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 419 (2002) 395-399
48. Alam A., et al. Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells. J. Exp. Med. 190 (1999) 1879-1890
49. Kennedy N.J., et al. Caspase activation is required for T cell proliferation. J. Exp. Med. 190 (1999) 1891-1896
50. DosReis G.A., et al. Cross-talk between apoptosis and cytokines in the regulation of parasitic infection. Cytokine Growth Factor Rev. 18 (2007) 97-105
51. Sehra S., et al. A role for caspases in controlling IL-4 expression in T cells. J. Immunol. 174 (2005) 3440-3446
52. Allen H.L., and Deepe Jr. G.S. Apoptosis modulates protective immunity to the pathogenic fungus Histoplasma capsulatum. J. Clin. Invest. 115 (2005) 2875-2885
53. Ramsdell F., et al. Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death. Int. Immunol. 6 (1994) 1545-1553
54. Zhang X., et al. Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis. J. Exp. Med. 185 (1997) 1837-1849
55. Oberg H.H., et al. Activation-induced T cell death: resistance or susceptibility correlate with cell surface fas ligand expression and T helper phenotype. Cell. Immunol. 181 (1997) 93-100
56. Varadhachary A.S., et al. Selective up-regulation of phosphatidylinositol 3′-kinase activity in Th2 cells inhibits caspase-8 cleavage at the death-inducing complex: a mechanism for Th2 resistance from Fas-mediated apoptosis. J. Immunol. 163 (1999) 4772-4779
57. Devadas S., et al. Granzyme B is critical for T cell receptor-induced cell death of type 2 helper T cells. Immunity 25 (2006) 237-247
58. Alexander C.E., et al. CD95 is required for the early control of parasite burden in the liver of Leishmania donovani-infected mice. Eur. J. Immunol. 31 (2001) 1199-1210
59. Huang F.P., et al. Mice defective in Fas are highly susceptible to Leishmania major infection despite elevated IL-12 synthesis, strong Th1 responses, and enhanced nitric oxide production. J. Immunol. 160 (1998) 4143-4147
60. Watanabe N., et al. Th1 and Th2 subsets equally undergo Fas-dependent and -independent activation-induced cell death. Eur. J. Immunol. 27 (1997) 1858-1864
61. DosReis G.A. Cell-mediated immunity in experimental Trypanosoma cruzi infection. Parasitol. Today 13 (1997) 335-342
62. + cytotoxic T cells after infection with Trypanosoma cruzi in naive or vaccinated mice. Infect. Immun. 74 (2006) 2477-2481
63. + T cells in Trypanosoma cruzi infection. Immunol. Rev. 201 (2004) 304-317
64. Rottenberg M.E., et al. Cytokine gene expression during infection of mice lacking CD4 and/or CD8 with Trypanosoma cruzi. Scand. J. Immunol. 41 (1995) 164-170
65. + T-cell expansion and promotes resistance to reinfection. Antimicrob. Agents Chemother. 46 (2002) 3790-3796
66. Kosec G., et al. Metacaspases of Trypanosoma cruzi: possible candidates for programmed cell death mediators. Mol. Biochem. Parasitol. 145 (2006) 18-28
67. Conceicao-Silva F., et al. The resolution of lesions induced by Leishmania major in mice requires a functional Fas (APO-1, CD95) pathway of cytotoxicity. Eur. J. Immunol. 28 (1998) 237-245
68. Muller U., et al. Concerted action of perforin and granzymes is critical for the elimination of Trypanosoma cruzi from mouse tissues, but prevention of early host death is in addition dependent on the FasL/Fas pathway. Eur. J. Immunol. 33 (2003) 70-78